SymBio Pharmaceuticals Limited (4582) — research page
JP · jp-cm-kg/TSE-GROWTH/4582 · as of 2026-11-06
Identity and listing
The issuer is SymBio Pharmaceuticals Limited, listed on the Growth Market under ticker 4582. The ISIN is not on the record, and the LEI is not on the record. The security type is Corporate, the sector is 3250 Pharmaceutical, and the jurisdiction is Japan (EDINET domestic filer). The segment is not on the record. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | SymBio Pharmaceuticals Limited | source · 2026-11-06 |
| exchange | Growth Market | source · 2026-11-06 |
| ticker | 4582 | source · 2026-11-06 |
| ISIN | not on the record | |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-06 |
| segment | not on the record | |
| sector | 3250 Pharmaceutical | source · 2026-11-06 |
| jurisdiction | Japan (EDINET domestic filer) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 10 filings in the twelve months to 2026-11-06, across 6 filing days. Of these, 2 are ad hoc, 2 are prospectus, 4 are regulatory filing, and 2 are results. The median gap between filing days is 7 days. The latest filing is dated 2026-08-21 and is a prospectus, 77 days before the record date. The Growth Market median is 42 days between filing days, 8.0 filings, and 85.0 days of latency across 598 issuers. The sector median on this market is 49.5 days between filing days, 8.0 filings, and 85.0 days of latency across 80 issuers.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 10 | 7 | 77 |
| exchange median: Growth Market (598 issuers) | 8 | 42 | 85 |
| sector median: 3250 Pharmaceutical (80 issuers) | 8 | 49.5 | 85 |
| date | type | category | filing |
|---|---|---|---|
| 2026-08-21 | prospectus | 040 | 訂正有価証券届出書（参照方式） |
| 2026-08-17 | prospectus | 有価証券届出書 (securities registration statement) | 有価証券届出書（参照方式） |
| 2026-08-10 | regulatory_filing | 135 | 確認書 |
| 2026-08-10 | results | 半期報告書 (half-year report) | 半期報告書－第22期(2026/01/01－2026/12/31) |
| 2026-04-17 | regulatory_filing | 190 | 訂正臨時報告書 |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is EY新日本有限責任監査法人. Its location is not on the record. Auditor changes are not on the record, as the market's record does not carry them.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag shows the issuer as listed, not halted.
Orderability
For the client category Qualified Institutional Investors the outcome is not determinable, because the subject's class carries no CFI to place on the scope bridge and no scope object names the class, so the subject is not shown within the scope. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.
| client category | outcome |
|---|---|
| Qualified Institutional Investors | not determinable: the rule states a product scope; the subject's class carries no CFI to place on the scope bridge, and no scope object names the class: the subject is not shown within the scope |
rule acm-68000/jp/suitability-principle-fiea-article-40/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations page as read, and the count is 0.
Open research
Two openly published research notes are on the record. Shared Research Inc. published on 2025-08-18, and Edison Investment Research Limited published on 2016-03-21.
| date | publisher | note | kind |
|---|---|---|---|
| 2025-08-18 | Shared Research Inc. | Research Coverage Report by Shared Research Inc. | issuer-sponsored |
| 2016-03-21 | Edison Investment Research Limited | SymBio Pharmaceuticals | issuer-sponsored |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, the earliest sealed date of the market is not on the record, and the date when the live record began is not on the record.
Sources
9 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)
- 10.2
- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)
- 10.3
- https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4582 (the disclosure lines)
- 10.4
- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)
- 10.5
- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XNE5 (the auditor)
- 10.6
- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://www.symbiopharma.com/en/ir/pdf/4582_EN_20250818.pdf (open research)
- 10.8
- https://www.symbiopharma.com/ir/pdf/symbio_pharmaceuticals_20160321e.pdf (open research)
- 10.9
- https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4582 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"ticker":"4582","exchange":"Growth Market"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:15f50cb7e13832f4.